EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Hepatitis B Virus Donor Positive to Recipient Negative (D+/R−) Heart and Lung Transplantation: Analysis From the Organ Procurement and Transplantation Network

Sara Belga iD, Robert C Wright, Stephen B Lee iD, Christine M Durand iD, Karen Doucette

Transplant Infectious Disease · 2025-09 · 27 (5)

DOI: 10.1111/tid.70054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, online erschienen am 22.07.2025. Verfasst von Sara Belga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Hepatitis B virus, Tissue Donors, Hepatitis B, Lung Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no funding for this study..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In nonendemic areas, transplantation from donors with hepatitis B virus (HBV) to recipients without HBV (D+/R−) has been proposed to expand the donor pool; however, data are limited. We aimed to evaluate the epidemiology of HBV in thoracic organ donors, assess HBV‐related thoracic organ nonuse, and determine the impact of HBV D+/R− in recipient outcomes.

Methods

Adult first‐time heart and lung transplant recipients with negative hepatitis B surface antigen (HBsAg) and HBV nucleic acid testing (NAT) were identified through the Organ Procurement and Transplantation Network between January 2004 and December 2022. Multivariable Cox regression models were built to assess the relationship of donor HBV status with death and graft failure.

Results

Our final cohort included 64,514 thoracic organ transplant recipients, 53 HBV D+/R− (0.1%) versus 64,461 (99.9%) HBV D−/R−, including 34,547 (53.5%) heart and 29,967 lung (46.5%) transplants. Donors with positive HBsAg or HBV NAT tests represented 0.31% of the donor pool. There were no reported cases of thoracic organ nonuse due to hepatitis, nor were there differences in the rates of HBV‐NAT or HBsAg positivity in used versus nonused thoracic organs. In multivariable modeling, HBV D+/R− was not associated with increased hazard of death (adjusted hazard ratio (aHR), 0.80 [95% CI, 0.30–2.13], p = 0.652) or graft failure (aHR, 0.73 [95% CI, 0.27–1.93], p = 0.522) at 1‐year.

Conclusions

HBV D+/R− thoracic organ transplantation does not appear to have a deleterious impact on recipient or graft survival. However, more data are needed to determine the long‐term risk of donor‐derived HBV infection and define the optimal management strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusTissue DonorsHepatitis BLung TransplantationHeart TransplantationHumansMaleFemaleMiddle AgedAdultTissue and Organ ProcurementHepatitis B Surface AntigensTransplant RecipientsRetrospective StudiesGraft RejectionAged

Stichwörter der Autor:innen

Donor poolHBV D+/R−heart transplantationhepatitis B virus (HBV)lung transplantation

Substanzen

Hepatitis B Surface Antigens

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada.
  • Immunity & Infection Research Centre, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada.
  • Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • British Columbia Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
  • Department of Medicine, Division of Infectious Diseases, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
  • The Johns Hopkins Transplant Research Center, Baltimore, Maryland, USA.

ORCID-Profile: Sara Belga, Stephen B Lee, Christine M Durand

Förderung

  • The authors received no funding for this study.

Zitieren

APA

Belga, S., Wright, R. C., Lee, S. B., Durand, C. M., & Doucette, K. (2025). Hepatitis B Virus Donor Positive to Recipient Negative (D+/R−) Heart and Lung Transplantation: Analysis From the Organ Procurement and Transplantation Network. Transplant Infectious Disease, 27(5). https://doi.org/10.1111/tid.70054

Vancouver

Belga S, Wright RC, Lee SB, Durand CM, Doucette K. Hepatitis B Virus Donor Positive to Recipient Negative (D+/R−) Heart and Lung Transplantation: Analysis From the Organ Procurement and Transplantation Network. Transplant Infectious Disease. 2025;27(5). doi:10.1111/tid.70054

BibTeX
@article{Belga2025,
  author = {Belga, Sara and Wright, Robert C and Lee, Stephen B and Durand, Christine M and Doucette, Karen},
  title = {Hepatitis B Virus Donor Positive to Recipient Negative (D+/R−) Heart and Lung Transplantation: Analysis From the Organ Procurement and Transplantation Network},
  journal = {Transplant Infectious Disease},
  year = {2025},
  volume = {27},
  number = {5},
  doi = {10.1111/tid.70054}
}
Kostenlos starten →